UCSF MEDICAL CENTER
1. Target Overview & Investment Thesis
UCSF MEDICAL CENTER is a 834-bed large academic medical center in SAN FRANCISCO, CA with $5.44B in net patient revenue and a -5.4% operating margin. The hospital serves a payer mix of 25.4% Medicare, 13.0% Medicaid, and 61.7% commercial.
Thesis: Undervalued. Our ML models identify $400.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.4% to 2.0% (+736bps).
| Net Revenue HCRIS | $5.44B |
| Current EBITDA COMPUTED | $-291.8M |
| Operating Margin COMPUTED | -5.4% |
| Occupancy HCRIS | 90.0% |
| Revenue / Bed COMPUTED | $6.5M |
| Net-to-Gross HCRIS | 26.6% |
| Distress Probability ML | 35.6% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -5.4% places it below the state median. Among 28 size-comparable peers (417-1668 beds), the median margin is -4.5%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (417-1668), prioritizing same-state peers. 28 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| UCSF MEDICAL CENTER (Target) | CA | 834 | $5.44B | -5.4% |
| STANFORD HEALTH CARE | CA | 657 | $6.76B | 3.7% |
| CEDARS-SINAI MEDICAL CENTER | CA | 908 | $3.92B | -5.5% |
| UC DAVIS MEDICAL CENTER | CA | 666 | $3.28B | -11.5% |
| UCSD MEDICAL CENTER | CA | 718 | $3.06B | -7.2% |
| RONALD REAGAN UCLA | CA | 446 | $2.62B | -6.8% |
| SANTA CLARA VALLEY MEDICAL CEN | CA | 805 | $2.55B | -29.4% |
| LOS ANGELES GENERAL MEDICAL CE | CA | 596 | $1.96B | 10.2% |
| COMMUNITY REGIONAL MEDICAL CEN | CA | 783 | $1.47B | -10.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $400.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $114.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $108.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $107.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $66.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $3.5M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-291.8M |
| + RCM Uplift | +$400.2M |
| Pro Forma EBITDA | $108.4M |
| Current Margin | -5.4% |
| Pro Forma Margin | 2.0% |
| WC Released (1x) | $208.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-448.9M | $2.08B | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-448.9M | $2.14B | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-404.0M | $3.31B | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-404.0M | $3.50B | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-493.7M | $222.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-493.7M | $84.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 28 hospitals with 417-1668 beds
- Same-state prioritization (n=29)
- Comp margins: P25=-10.9% / P50=-4.5% / P75=4.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.